Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

Raptor Pharmaceuticals Corp. (RPTP)

-NasdaqGM
9.16 Up 0.54(6.26%) Jul 30, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 12,134   10,248   6,603   21  
Cost of Revenue1,314  786  442  425  
Gross Profit 10,820   9,462   6,161   (404)
Operating Expenses
Research Development9,547  7,759  6,791  6,215  
Selling General and Administrative12,064  12,372  8,334  9,379  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (10,791) (10,669) (8,964) (15,998)
Income from Continuing Operations
Total Other Income/Expenses Net(1,115)1,321  (6,026)(7,048)
Earnings Before Interest And Taxes(11,906)(9,348)(14,990)(23,046)
Interest Expense2,979  2,744  2,287  1,075  
Income Before Tax(14,885)(12,092)(17,277)(24,121)
Income Tax Expense6   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(14,891)(12,092)(17,277)(24,121)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (14,891) (12,092) (17,277) (24,121)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (14,891) (12,092) (17,277) (24,121)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.